Latest News and Press Releases
Want to stay updated on the latest news?
-
MOORESTOWN, N.J., Oct. 28, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces today that...
-
MOORESTOWN, N.J., March 19, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced...
-
MILTON, GA, Jan. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Attis Industries Inc. (NASDAQ: ATIS) (the “Company” or “Attis”), a diversified innovation and technology holding company focused on...
-
Hosts Portland Uncorked! Introduces New Company Division and Sponsors Leadership Awards Luncheon MOORESTOWN, N.J., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:...
-
MOORESTOWN, N.J., July 17, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (TRHC) (NASDAQ:TRHC) held its annual advisory panel meeting of PACE directors June 21 – 22, 2018 in Philadelphia, PA and at...
-
ST. LOUIS and MOORESTOWN, N.J., July 11, 2018 (GLOBE NEWSWIRE) -- Capstone Performance Systems, a Tabula Rasa HealthCare (NASDAQ:TRHC) Company announced today the closure on new contracts with six...
-
MOORESTOWN, N.J., June 13, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare (NASDAQ:TRHC) President and Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA announced...
-
MOORESTOWN, N.J., May 09, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying new, medication risk...
-
MOORESTOWN, N.J., April 03, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC) has been awarded a sixth place ranking out of 40 for midsized companies on the 2018 Top...
-
MOORESTOWN, N.J., March 20, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety by deploying new medication...